Babafemi O Taiwo

  • 1452 Citations
20002023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Infectious Disease

Training Experience

1996Residency, Berkshire Medical Center
2006Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MBBS, University of Ibadan, Nigeria

… → 1991

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Nigeria Medicine & Life Sciences
Viral Load Medicine & Life Sciences
efavirenz Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2023

Research Output 2000 2019

Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus

Erlandson, K. M., Perez, J., Abdo, M., Robertson, K., Ellis, R. J., Koletar, S. L., Kalayjian, R., Taiwo, B. O., Palella Jr, F. J. & Tassiopoulos, K., Jan 1 2019, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68, 1, p. 131-138 8 p.

Research output: Contribution to journalArticle

HIV
Health
Activities of Daily Living
CD4 Lymphocyte Count
Observational Studies

Physical Activity Is Associated With Lower Odds of Cognitive Impairment in Women but Not Men Living With Human Immunodeficiency Virus Infection

Chow, F. C., Makanjuola, A., Wu, K., Berzins, B., Kim, K-Y. A., Ogunniyi, A., Ellis, R. J., Robertson, K., Tassiopoulos, K. & Taiwo, B. O., Jan 7 2019, In : The Journal of infectious diseases. 219, 2, p. 264-274 11 p.

Research output: Contribution to journalArticle

Virus Diseases
HIV
Exercise
Logistic Models
Women's Health
8 Citations

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants with HIV-1 RNA <500000 Copies/mL

Taiwo, B. O., Zheng, L., Stefanescu, A., Nyaku, A., Bezins, B., Wallis, C. L., Godfrey, C., Sax, P. E., Acosta, E., Haas, D., Smith, K. Y., Sha, B., Van Dam, C. & Gulick, R. M., May 17 2018, In : Clinical Infectious Diseases. 66, 11, p. 1689-1697 9 p.

Research output: Contribution to journalArticle

Lamivudine
HIV-1
RNA
Mutation
CD4 Lymphocyte Count

Discordant rapid HIV tests: lessons from a low-resource community

Adetunji, A. A., Kuti, M. A., Audu, R. A., Muyibi, S. A., Imhansoloeva, M., Mosuro, O. A., Solanke, E. A., Akpa, O. M., Irabor, A. E., Ladipo, M. M. A., Berzins, B., Robertson, K., Ogunniyi, A., Adewole, I. F. & Taiwo, B. O., Jan 1 2018, In : HIV Medicine. 19, 1, p. 72-76 5 p.

Research output: Contribution to journalArticle

HIV
HIV Infections
HIV-1
HIV Antigens
Odds Ratio
6 Citations

Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

Taiwo, B. O., Marconi, V. C., Berzins, B., Moser, C. B., Nyaku, A. N., Fichtenbaum, C. J., Benson, C. A., Wilkin, T., Koletar, S. L., Colasanti, J., Acosta, E. P., Li, J. Z. & Sax, P. E., May 17 2018, In : Clinical Infectious Diseases. 66, 11, p. 1794-1797 4 p.

Research output: Contribution to journalArticle

Lamivudine
HIV-1
Drug Resistance
Randomized Controlled Trials
Maintenance